Study on Lipid Profile Changes in Plasma and Intestinal Mucosa of Patients With Inflammatory Bowel Disease
Observational · No treatment assigned · 1 site · First Affiliated Hospital of Harbin Medical University
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: Inflammatory Bowel Diseases. This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Ages 18 to 80
- Any sex
- Healthy volunteers accepted
Some of the main requirements, copied from the record:
- Patients with inflammatory bowel disease; aged 18-80 years; all cases agreed to participate in the study.
- Healthy volunteers who agreed to participate in the study.
There are also 1 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 90 participants are expected to take part.
- Start date: 2024-12 (planned).
- Main results expected around 2025-02-25 (estimate from the record).
- 1 study site listed in China.
Main thing being measured
- Differential lipid composition between disease and healthy groups (14 weeks)
In the researchers’ words
This study aimed to demonstrate the characteristic lipid profile changes in patients with inflammatory bowel disease.
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Not yet recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | Inflammatory Bowel Diseases |
| Lead sponsor | First Affiliated Hospital of Harbin Medical University |
| Enrollment | 90 (estimated) |
| Start date | 2024-12 |
| Primary completion (est.) | 2025-02-25 |
| First posted | 2024-11-08 |
| Last updated | 2024-12-12 |
| Official title | Observational Study of Changes in Plasma and Intestinal Mucosa Lipid Profiles in Patients With Inflammatory Bowel Disease |
| ClinicalTrials.gov ID | NCT06680076 |
Interventions
- None listed
Full eligibility criteria (from the record)
Inclusion Criteria: * Patients with inflammatory bowel disease; aged 18-80 years; all cases agreed to participate in the study. * Healthy volunteers who agreed to participate in the study. Exclusion Criteria: * Patients with severe heart disease; patients with severe kidney disease; patients with low blood pressure; patients with severe infections such as sepsis or pneumonia; patients who have used immunosuppressants such as 6-mercaptopurine, imidazole thiopurine, and cyclosporine within a short period, and women during pregnancy; patients who are post-colon resected; patients who disagreed to participate in the study.
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| Carol | Harbin, Heilongjiang | China |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.